From January 1, 2024 to March 18, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 729,034 shares, representing 0.94% for $1.66 million under the buyback announced on April 27, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.39 USD | -0.86% |
|
-6.42% | +154.65% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+154.65% | 5.23B | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.07% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- VKTX Stock
- News Viking Therapeutics, Inc.
- Tranche Update on Viking Therapeutics, Inc.'s Equity Buyback Plan announced on April 27, 2022.